Non-Transferrin-Bound Iron during Blood Transfusion Cycles in β-Thalassemia Major
- 1 November 2005
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1054 (1), 429-432
- https://doi.org/10.1196/annals.1345.074
Abstract
Serum non-transferrin-bound iron (NTBI) levels assessed at arbitrary time points during transfusion cycles may not be representative if NTBI is undergoing significant changes during transfusion cycles. In 15 patients with beta-thalassemia major (age: 21 +/- 6 years, liver iron concentration: 2200 +/- 1200 microg/g-liver), NTBI and other hematologic parameters (transferrin saturation, transferrin receptor) were measured weekly. The largest variation of NTBI levels between individual patients was observed at midcycle. For long-term monitoring of NTBI levels, a particular time point relative to the last blood transfusion should be selected for blood drawing.This publication has 3 references indexed in Scilit:
- Iron Overload and Antioxidant Status in Patients with β‐Thalassemia MajorAnnals of the New York Academy of Sciences, 1998
- Nontransferrin-bound Iron in Serum of Patients Receiving Bone Marrow TransplantsFree Radical Biology & Medicine, 1997
- A direct method for quantification of non-transferrin-bound ironAnalytical Biochemistry, 1990